India may take WTO action against EU over drug clinical trials

April 15, 2015 6:47 AM

8 0

MUMBAI, April 15 (Reuters) - India may go to the World Trade Organisation (WTO) if the European Union does not reconsider its decision to suspend the sale of about 700 generic drugs that were approved based on clinical trials by GVK Biosciences Pvt Ltd, the firm's CEO said.

The European Medicines Agency (EMA) suspension became effective in January, a month after France, Germany, Belgium and Luxembourg suspended the sale of 25 generic drugs that were approved based on trials conducted by GVK Biosciences.

Also read: Official: Canada expected to legalize marijuana by July 2018

Read more

To category page